Organization | Fidec Corporation

Fidec Corporation Report issue

Foundation Phase 2 Phase 3 Phase 4

Founded: Coral Gables Florida United States (2001)

Organization Overview

First Clinical Trial

2013

NCT01831050

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Fidec Corporation

Active Ingredients

Drugs in Phase 4 Trials (4)

bivalent oral polio vaccine (bopv), type 1 and type 3 (3 trials)

live oral poliovirus type 1, 2 and 3 (3 trials)

monovalent oral polio vaccines (mopv2) (1 trial)

Drugs in Phase 3 Trials (3)

f-ipv (2 trials)

novel opv2 (1 trial)

novel oral polio vaccine type 2 (nopv2) (1 trial)

Drugs in Phase 2 Trials (1)

monovalent oral polio vaccines (mopv1) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Poliomyelitis (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 9
# of Trial APIs: 8